Dimensional Fund Advisors
GSK icon

Dimensional Fund Advisors’s GSK GSK Stock Holding History

Dimensional Fund Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$141M Buy
2,691,698
+104,931
+4% +$5.55M 0.03% 929
2026
Q1 		$143M Buy
2,586,767
+87,313
+3% +$4.73M 0.03% 819
2025
Q4 		$123M Buy
2,499,454
+4,922
+0.2% +$230K 0.03% 918
2025
Q3 		$108M Sell
2,494,532
-87,843
-3% -$3.43M 0.02% 999
2025
Q2 		$99.2M Buy
2,582,375
+1,588
+0.1% +$60.7K 0.02% 1017
2025
Q1 		$100M Sell
2,580,787
-17,783
-0.7% -$651K 0.02% 978
2024
Q4 		$87.9M Buy
2,598,570
+18,492
+0.7% +$666K 0.02% 1140
2024
Q3 		$105M Buy
2,580,078
+323,758
+14% +$13.2M 0.03% 989
2024
Q2 		$86.9M Buy
2,256,320
+569,614
+34% +$24M 0.02% 1072
2024
Q1 		$72.3M Sell
1,686,706
-90,989
-5% -$3.75M 0.02% 1211
2023
Q4 		$65.9M Buy
1,777,695
+18,585
+1% +$667K 0.02% 1239
2023
Q3 		$63.8M Buy
1,759,110
+58,225
+3% +$2.07M 0.02% 1162
2023
Q2 		$60.6M Buy
1,700,885
+175,731
+12% +$6.3M 0.02% 1220
2023
Q1 		$54.3M Sell
1,525,154
-14,338
-0.9% -$502K 0.02% 1256
2022
Q4 		$54.1K Sell
1,539,492
-323,313
-17% -$10.8M 0.02% 1259
2022
Q3 		$54.8M Sell
1,862,805
-3,357
-0.2% -$127K 0.02% 1151
2022
Q2 		$102M Buy
1,866,162
+1,396
+0.1% +$77.1K 0.04% 723
2022
Q1 		$102M Sell
1,864,766
-2,903
-0.2% -$158K 0.03% 841
2021
Q4 		$103M Buy
1,867,669
+2,804
+0.2% +$146K 0.03% 861
2021
Q3 		$89.1M Sell
1,864,865
-42,347
-2% -$2.13M 0.03% 933
2021
Q2 		$94.9M Sell
1,907,212
-61,157
-3% -$2.94M 0.03% 897
2021
Q1 		$87.8M Sell
1,968,369
-2,464
-0.1% -$112K 0.03% 937
2020
Q4 		$90.7M Sell
1,970,833
-250,087
-11% -$11.5M 0.03% 829
2020
Q3 		$104M Sell
2,220,920
-322,330
-13% -$16.1M 0.04% 548
2020
Q2 		$130M Sell
2,543,250
-2,300
-0.1% -$118K 0.06% 381
2020
Q1 		$121M Buy
2,545,550
+380,392
+18% +$20.3M 0.06% 298
2019
Q4 		$127M Buy
2,165,158
+159,670
+8% +$8.88M 0.05% 549
2019
Q3 		$107M Buy
2,005,488
+134,449
+7% +$6.92M 0.04% 626
2019
Q2 		$93.6M Buy
1,871,039
+218,617
+13% +$11M 0.04% 750
2019
Q1 		$86.3M Buy
1,652,422
+236,535
+17% +$11.8M 0.03% 802
2018
Q4 		$67.6M Buy
1,415,887
+70,518
+5% +$3.47M 0.03% 915
2018
Q3 		$67.6M Buy
1,345,369
+32,825
+3% +$1.67M 0.03% 1106
2018
Q2 		$66.1M Sell
1,312,544
-25,156
-2% -$1.27M 0.03% 1082
2018
Q1 		$65.3M Buy
1,337,700
+54,849
+4% +$2.55M 0.03% 1028
2017
Q4 		$56.9M Buy
1,282,851
+4,161
+0.3% +$192K 0.02% 1209
2017
Q3 		$64.9M Buy
1,278,690
+4,607
+0.4% +$234K 0.03% 990
2017
Q2 		$68.7M Buy
1,274,083
+105,027
+9% +$5.6M 0.03% 865
2017
Q1 		$61.6M Buy
1,169,056
+7,982
+0.7% +$405K 0.03% 932
2016
Q4 		$55.9M Buy
1,161,074
+23,552
+2% +$1.16M 0.03% 1014
2016
Q3 		$61.3M Buy
1,137,522
+39,397
+4% +$2.16M 0.03% 830
2016
Q2 		$59.5M Buy
1,098,125
+34,915
+3% +$1.84M 0.03% 785
2016
Q1 		$53.9M Buy
1,063,210
+59,196
+6% +$2.95M 0.03% 834
2015
Q4 		$50.6M Buy
1,004,014
+47,484
+5% +$2.42M 0.03% 841
2015
Q3 		$46M Buy
956,530
+1,320
+0.1% +$68.7K 0.03% 881
2015
Q2 		$49.7M Buy
955,210
+5,924
+0.6% +$334K 0.03% 868
2015
Q1 		$54.8M Buy
949,286
+65,300
+7% +$3.74M 0.03% 748
2014
Q4 		$47.2M Buy
883,986
+101,678
+13% +$5.69M 0.03% 819
2014
Q3 		$45M Buy
782,308
+45,822
+6% +$2.81M 0.03% 777
2014
Q2 		$49.2M Buy
736,486
+29,531
+4% +$2M 0.03% 720
2014
Q1 		$47.2M Buy
706,955
+182,650
+35% +$12.3M 0.04% 693
2013
Q4 		$35M Buy
524,305
+62,031
+13% +$4.02M 0.03% 916
2013
Q3 		$29M Buy
462,274
+98,826
+27% +$6.36M 0.03% 995
2013
Q2 		$22.7M Buy
+363,448
New +$23.1M 0.02% 1134

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors's GSK Position: Q2 2026 in Review

Dimensional Fund Advisors increased its GSK (GSK) stake by 4.1% in Q2 2026, buying an estimated $5.55M and bringing the position to 2,691,698 shares worth $141M. The position accounts for 0.03% of the portfolio, ranked #929.

Dimensional Fund Advisors first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $143M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Dimensional Fund Advisors held 2,691,698 shares of GSK worth $141M as of Q2 2026.
  • Dimensional Fund Advisors bought 104,931 GSK shares in Q2 2026, an estimated $5.55M.
  • GSK made up 0.03% of Dimensional Fund Advisors's portfolio in Q2 2026, its #929 holding.
  • Dimensional Fund Advisors first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
  • Dimensional Fund Advisors's GSK position peaked at $143M in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.